Is Merck & Co. (MRK) the Low Volatility Stock to Buy According to Billionaire Ken Fisher?
We recently published a list of 10 Low Volatility Stocks to Buy According to Billionaire Ken Fisher. In this article, we are ...
Merck & Co.: Looming Patent Expiries For Key Drugs Weaken Longer-Term Outlook
Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.
Why Merck & Co. Inc. (MRK) Performed Worst On Tuesday?
Tuesday’s 10 Worst Performers. In this article, we are going to take a look at where Merck & Co. Inc. (NYSE:MRK) stands ...
Here is Why Jim Cramer Is Bullish About Merck (MRK)
We recently published a list of Jim Cramer Focused On These 9 Stocks Recently. In this article, we are going to take a look ...
Positive phase III data gives Merck potential boost for blockbuster Keytruda in injection form
When topline phase III data was released in November, hinting at the potential of success, Jefferies analyst Akash Tiwari ...
Forget S&P 500 And Buy These Dividend Icons Instead
Read more on 2 durable dividend stocks that offer higher yields and strong cash flows, outperforming the S&P 500 in value, ...
Zacks.com on MSN1d
Merck (MRK) Gains As Market Dips: What You Should Know
In the latest market close, Merck (MRK) reached $88.11, with a +0.27% movement compared to the previous day. The stock exceeded the S&P 500, which registered a loss of 1.12% for the day. Meanwhile, ...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MRK
NEW YORK, NY / ACCESS Newswire / March 25, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE:MRK) between February 3, 2022 and ...
Gamestop, FST Corp, Merck, UPS, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
The U.S. stock market had a mixed session on Tuesday. The Nasdaq Composite climbed nearly 80 points, or 0.5%, closing at ...
MRK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Merck & Co., Inc. to Contact the Firm Today!
NEW YORK CITY, NY / ACCESS Newswire / March 12, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies ...
Merck Partners With Hengrui Pharma In $1.77 Billion Deal For Cardiovascular Treatment
Merck secures global rights to HRS-5346, an investigational Lp(a) inhibitor, in a deal with Hengrui Pharma worth up to $1.97 billion.
Gardasil maker completes $1B North Carolina expansion — more growth on the way
New facility will manufacture HPV vaccines Gardasil and Gardasil 9. Merck plans to invest $8 billion more in U.S. by 2028. A ...